Business
Behind the Vail: Mountain profits leans heavily on pass sales

Behind the Vail: Mountain profits leans heavily on pass sales

Behind the Vail

When choosing where to go skiing, the après-ski and chocolat-chaud-on-the-slopes culture of resorts in Europe is a popular pull for visitors from all over the world, with the continent attracting nearly 200 million visitors every year. But, for those opting to ski stateside, chances are that you might consider one of North America’s larger destinations such as Park City resort in Utah, Whistler Blackcomb, or Breckenridge in Colorado — all of which are owned by one company: Vail Resorts.

Vail is America’s largest ski resort owner and operator. Now a nearly $9 billion company, Vail can trace its roots back to 1962, when Earl Eaton and WW2 veteran Pete Seibert opened the company’s eponymous resort in Colorado. Operating for more than two decades as an independent business, Vail — which had expanded by building the neighboring resort Beaver Creek — was eventually acquired by George Gillett, a local businessman who oversaw a massive renovation of the Vail properties.

It wasn’t until Gillett Holdings filed for bankruptcy in 1991, which led to Vail Resorts being scooped up by private equity giant Apollo the year after, that the foundation was set for the company to become the largest resort owner in the world. Two jewels of the portfolio, Breckenridge and Keystone, were acquired in 1997, and in the following decades, more were added at an increasing pace. Today, Vail boasts ownership of 34 ski resorts in the US and a global total of 41, playing host to nearly 20 million skiers last year.

As you might imagine, running a ski resort is not a capital-light endeavor. Before you make a single dollar, you need to plow millions of dollars into acquiring or leasing suitable acreage, build miles of lifts, groom pistes and ski runs, construct accommodation, and build amenities… all of which needs to be done halfway, or sometimes the entire way, up a mountain.

Once you’ve done all of that, with enough visitors the economics become profitable. Labor costs — think lift operators and engineers, retail staff, ski instructors, snow groomers, etc. — account for more than 40% of the mountain segment costs, but the company also faces serious costs in snowmaking operations, an expense lumped under other, as ski resorts look to artificial snow to make up the snow shortfall.

More Business

See all Business
business

Hims to stop offering copy of Wegovy pill following FDA scrutiny

Hims & Hers said it has decided to stop offering its newly launched copycat version of Novo Nordisk’s Wegovy pill, after the telehealth company drew criticism from the Food and Drug Administration. 

“Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment,” Hims wrote on X.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Shares of Hims are down double digits in premarket trading on Monday, while Novo Nordisk ADRs are up more than 6% as of 5:20 a.m. ET.

On Friday afternoon, the FDA said it would take “decisive steps” to restrict GLP-1 compounding. Department of Health and Human Services General Counsel Mike Stuart said on social media Friday he had referred Hims to the Department of Justice “for investigation for potential violations by Hims of the Federal Food, Drug, and Cosmetic Act and applicable Title 18 provisions.”

Hims launched the product last week, a seeming copy of a recently released and patented drug, which immediately drew fire from Novo Nordisk and regulators.

Hims oral semaglutide

Hims, long flying under regulators’ radar, finally strikes a nerve with its Wegovy pill copy

It’s unclear if the pill Hims is selling works or if the FDA will allow it.

$1.3M

There’s still plenty of money to be made in brainrot. The top 1,000 Roblox creators earned an average of $1.3 million in 2025 — up 50% from the year prior — according to CEO Dave Baszucki on the company’s fourth-quarter earnings call.

Roblox paid out $1.5 billion to creators last year, meaning its top 1,000 creators took home about 87% of the total pool.

Like other creator economy giants, Roblox rewards its biggest creators for their contributions to user engagement. Creator-made titles like “Grow a Garden” and “Steal a Brainrot” substantially boosted playing time over the course of the year. In September, the company increased its developer exchange rate, or the ratio of in-game currency to cash payout, by 8.5%.

Texas Governor Abbott And Google Make Economic Development Announcement In Midlothian

Alphabet could buy some pretty huge businesses with the amount of money it plans to spend this year

AI outlays have gone full nut-nut. Even Google, one of the most capital-efficient businesses of all time in its heyday, is spending like there’s no tomorrow.

Tom Jones2/6/26

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.